HOTH vs KEY · rev $1.24B vs P/E 13, rev $7.51B
Hoth Therapeutics Inc (HOTH) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Hoth Therapeutics Inc (HOTH) is a biotechnology company listed on US.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported HOTH revenue for 2024-03-31 was $1.24B. Net income was -$2.1M. HOTH currently screens at market cap $15.5M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
HOTH currently screens at market cap $15.5M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the HOTH and KEY stock pages for the full models.
Not investment advice.